Preliminary scientific studies suggest conolidine might inhibit distinct ion channels, minimizing neuronal excitability and limiting agony alerts. This mechanism is especially related in neuropathic agony, where by abnormal signaling triggers persistent soreness. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pathways